Summary: Nebulization is gaining popularity as a treatment alternative, and many drugs are used unlabeled in a nebulized form, including the opioids, lidocaine, magnesium sulfate, amphotericin B ...

The limited amount of research devoted to the nebulization of the drugs listed above and the lack of definitive preparation guidelines presented in the research can lead to confusion in deciding ...

Liquidia Corp. saw heightened retail chatter Monday after Bank of America increased its stock price target to $25 from $22 ...

On Friday, the U.S. Food and Drug Administration (FDA) approved Liquidia Corporation’s LQDA Yutrepia (treprostinil) ...

Liquidia Corporation ( NASDAQ: LQDA) said on Friday that the U.S. FDA has approved Yutrepia inhalation powder, a prostacyclin ...

A groundbreaking study has revealed that supplementing vasopressin, a hormone linked to social behavior, may improve social ...

The FDA has approved a novel inhalation powder for pulmonary arterial hypertension and interstitial lung disease-associated ...

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB. Explore delivery mechanisms, key technologies, and future breakthroughs.